Literature DB >> 15922633

Spontaneous osteonecrosis of the knee: biochemical markers of bone turnover and pathohistology.

C E Berger1, A Kröner, K H Kristen, M Minai-Pour, T Leitha, A Engel.   

Abstract

OBJECTIVE: The aim of this study was to evaluate bone metabolism in patients with spontaneous osteonecrosis (ON) of the medial femoral condyle.
METHOD: In 22 consecutive patients, undergoing total knee arthroplasty, biochemical markers of bone metabolism were measured in aspirates from cancellous bone and in samples obtained simultaneously from peripheral blood. Specimens of the medial femoral condyle were available for histologic examination and the lesion size, assessed on radiographs, was compared with the results from bone turnover measurements. Twenty patients with osteoarthritis (OA) of the knee served as a control. Bone-specific alkaline phosphatase (bone ALP), osteocalcin (OC), procollagen type I N-terminal propeptide (PINP), and C-terminal cross-linking telopeptide (ICTP) were studied.
RESULTS: Mean serum levels of analytes were not different in patients with ON and OA. The serum concentrations averaged 16.2 vs 13.3 ng/mL (OC), 10.2 vs 12.1 ng/mL (bone ALP), 4.6 vs 4.1 ng/mL (ICTP), and 33.2 vs 40.4 ng/mL (PINP) in patients with ON and OA, respectively. In samples obtained from cancellous bone, mean concentrations of all markers were elevated significantly when compared to serum levels. The mean marker concentrations in samples obtained from cancellous bone were 33.8 vs 43.3 ng/mL (OC), 34.6 vs 37.3 ng/mL (bone ALP), 64.8 vs 36.1 ng/mL (ICTP, P=0.02), and 208.0 vs 176.2 ng/mL (PINP) in patients with ON and OA, respectively. The lesion size was at mean 440.5+/-275.8mm(2) in knees with ON and did not correlate with either serum or bone concentrations of all markers tested (P>0.1).
CONCLUSION: The marked elevation of markers in samples obtained from cancellous bone pointed at increased turnover in both diseases when compared to healthy individuals. In line with histologic findings of necrosis of subchondral bone, focal degradation of collagen type I was more pronounced in knees with ON. Mean serum concentrations of all markers, however, were not different from healthy individuals and thus did not provide any useful clue in the diagnosis spontaneous ON.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922633     DOI: 10.1016/j.joca.2005.04.003

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  5 in total

1.  Thrombophilia-Associated Factors in Patients with Spontaneous Osteonecrosis of the Knee.

Authors:  Niv Marom; Jonathan Ej Koch; Yiftah Beer; Martin Ellis; Gil Ganot; Meir Nyska; Guy Maoz; Iftach Hetsroni
Journal:  Cartilage       Date:  2018-01-07       Impact factor: 4.634

2.  Subchondral osteopenia and accelerated bone remodelling post-ovariectomy - a possible mechanism for subchondral microfractures in the aetiology of spontaneous osteonecrosis of the knee?

Authors:  J C Holland; O Brennan; O D Kennedy; S Rackard; F J O'Brien; T C Lee
Journal:  J Anat       Date:  2012-11-21       Impact factor: 2.610

3.  Characterization and pathological characteristics of spontaneous osteonecrosis of the knee.

Authors:  Simon C Mears; Edward F McCarthy; Lynne C Jones; David S Hungerford; Michael A Mont
Journal:  Iowa Orthop J       Date:  2009

4.  Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies.

Authors:  Tae-Hwan Kim; Won-Gyo Seo; Chul-Hong Koo; Jae-Hoon Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-08-24

5.  Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization.

Authors:  Aswath Narayanan; Prakash Khanchandani; Roshan M Borkar; Chandrashekar Reddy Ambati; Arun Roy; Xu Han; Ritesh N Bhoskar; Srinivas Ragampeta; Francis Gannon; Vijaya Mysorekar; Balasubramanyam Karanam; Sai Muthukumar V; Venketesh Sivaramakrishnan
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.